The Delaware court ruling allows Teva and Apotex to continue selling generic alternatives to HETLIOZ.
Live Poll
Should pharmaceutical companies be held responsible for off-label uses of their medications by patients?
September 30, 2026
Delaware Surgeon General Outlined Value-Based Care ShiftState health programs will transition to new models, impacting providers serving 40% of the Delaware population.
September 25, 2026
Mylan Filed Lawsuit to Develop Generic WegovyThe drug manufacturer seeks a federal court ruling to bypass current patent protections for the GLP-1 medication.
September 24, 2026
Delaware Awarded $23 Million for Rural Health UpgradesHealthcare operators will leverage federal funds to scale technology, mobile units, and workforce capacity.
September 23, 2026
Delaware Court Heard Arguments on Vividion Sale PriceInvestors are challenging the $2 billion acquisition price, claiming intellectual property valuation concerns.
September 21, 2026
Delaware Health Officials Called Spending Trends UnsustainableHealthcare operators should anticipate tighter controls on service pricing as state officials address rising costs.
